On Sept. 19, KCRA 3 Anchor Edie Lambert interviewed Costanzo Di Perna, MD, Medical Director, Mercy Cancer Institute, about a new treatment for Gastroesophageal Reflux Disease (GERD), a chronic, often progressive disease resulting from a weak lower esophageal sphincter that allows harmful gastric fluid to reflux into the esophagus, resulting in both pain and injury to the esophageal lining.
The LINX Reflux Management System is a small implant comprised of interlinked titanium beads with magnetic cores. The magnetic attraction between the beads augments the existing esophageal sphincter’s barrier function to prevent reflux. The device is implanted using a standard minimally invasive laparoscopic procedure and is an alternative to the more anatomically disruptive fundoplication, commonly used in surgical anti-reflux procedures.
KCRA 3 interviewed Dr. Di Perna and a patient who recently had the LINX procedure, who says she feels like a new person since the surgery.
Mercy San Juan Medical Center is one of the first sites in Northern California to offer LINX.